Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials (Q35961855)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

0 references

1 reference

Europe PubMed Central

Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials (English)

1 reference

Europe PubMed Central

11 August 2017

0 references

0 references

0 references

0 references

osteoarthritic knee

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Lars Slørdal

1 reference

Europe PubMed Central

11 August 2017

author name string

Jan Magnus Bjordal

1

1 reference

Europe PubMed Central

11 August 2017

Anne Elisabeth Ljunggren

2

1 reference

Europe PubMed Central

11 August 2017

Atle Klovning

3

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

23 November 2004

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

329

1 reference

Europe PubMed Central

11 August 2017

7478

1 reference

Europe PubMed Central

11 August 2017

1317

1 reference

Europe PubMed Central

11 August 2017

Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Single dose oral celecoxib for postoperative pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Nonsteroidal anti-inflammatory drugs and heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

The double-edged sword of COX-2 selective NSAIDs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Diagnostic cervical zygapophyseal joint blocks for chronic cervical pain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Celecoxib versus diclofenac in the management of osteoarthritis of the knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Dr

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Meta-analyses to evaluate analgesic interventions: a systematic qualitative review of their methodology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

The statistical basis of meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

The efficacy of diflunisal in osteoarthritis of the knee. A Canadian Multicenter Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

2 October 2017

Lessons from the withdrawal of rofecoxib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

11 July 2018

Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

11 July 2018

Impaired postural control of the lumbar spine is associated with delayed muscle response times in patients with chronic idiopathic low back pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

11 July 2018

Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

11 July 2018

NSAIDs and increased blood pressure. What is the clinical significance?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

11 July 2018

The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

11 July 2018

Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Comparing the efficacy of cyclooxygenase 2–specific inhibitors in treating osteoarthritis: Appropriate trial design considerations and results of a randomized, placebo‐controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

The effect of flurbiprofen and tiaprofenic acid on serum cytokine levels of patients with osteoarthrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Delayed onset of electromyographic activity of vastus medialis obliquus relative to vastus lateralis in subjects with patellofemoral pain syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Effect sizes for interpreting changes in health status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=534841

24 September 2018

Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is a "clinically meaningful" reduction in pain?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporomandibular disorders: MR assessment of inflammatory changes in the posterior disk attachment during the menstrual cycle

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Range of joint motion and disability in patients with osteoarthritis of the knee or hip

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long‐term effects of non‐steroidal anti‐inflammatory drugs in osteoarthritis of the knee: a randomized placebo‐controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The iatrogenic costs of NSAID therapy: a population study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WOMAC osteoarthritis index. Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis. Western Ontario and MacMaster Universities

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15561731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.38273.626655.63

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35961855&oldid=1975233325"